The hepatitis B virus X gene induces p53-mediated programmed cell death.
暂无分享,去创建一个
G. Natoli | M. Levrero | S. Pagano | P. L. Puri | V. Burgio | P. Chirillo | C. Balsano | Vito L. Burgio
[1] G. Natoli,et al. MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes , 1997, Oncogene.
[2] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[3] K. Vousden,et al. p53 in signaling checkpoint arrest or apoptosis. , 1996, Current opinion in genetics & development.
[4] G. Blandino,et al. Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes , 1996, Molecular and cellular biology.
[5] C. Harris,et al. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. , 1995, Cancer research.
[6] R. Lucito,et al. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. , 1995, The EMBO journal.
[7] G. Natoli,et al. Resistance to Fas-mediated apoptosis in human hepatoma cells. , 1995, Oncogene.
[8] E. Shaulian,et al. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. , 1995, Genes & development.
[9] O. Andrisani,et al. The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Greenblatt,et al. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation , 1995, Journal of virology.
[11] M. Kastan,et al. Growth factor modulation of p53-mediated growth arrest versus apoptosis. , 1995, Genes & development.
[12] S. Elledge,et al. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein , 1995, Journal of virology.
[13] J. Cheong,et al. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. , 1995, The EMBO journal.
[14] H. Hermeking,et al. Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] R. Schneider,et al. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[16] G. Natoli,et al. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. , 1994, Oncogene.
[17] H. Hermeking,et al. Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.
[18] A. Sette,et al. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope , 1994, The Journal of experimental medicine.
[19] E. White. p53, guardian of Rb , 1994, Nature.
[20] M. Karin,et al. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.
[21] E. May,et al. Induction of apoptosis by transiently transfected metabolically stable wt p53 in transformed cell lines. , 1994, Cell death and differentiation.
[22] K. Koike,et al. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. , 1994, The Journal of clinical investigation.
[23] H. Pan,et al. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. , 1994, Genes & development.
[24] C. Harris,et al. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[25] F. Zoulim,et al. Woodchuck hepatitis virus X protein is required for viral infection in vivo , 1994, Journal of virology.
[26] K. Koike,et al. Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor. , 1994, Oncogene.
[27] G. Natoli,et al. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX , 1994, Molecular and cellular biology.
[28] G. Natoli,et al. Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. , 1993, Virology.
[29] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[30] J. Nevins,et al. Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.
[31] W. Rutter,et al. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[32] G. Natoli,et al. The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements. , 1993, Oncogene.
[33] E. White,et al. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.
[34] R. Anderson,et al. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks , 1993, Journal of virology.
[35] P. Hofschneider,et al. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway , 1993, Nature.
[36] M. Fritsche,et al. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. , 1993, Oncogene.
[37] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[38] G. Natoli,et al. Characterization of the hepatitis B virus preS/S region encoded transcriptional transactivator. , 1992, Virology.
[39] Jean‐Pierre Martin,et al. Altered pathogenicity in the liver induced by a mouse hepatitis virus type 3 thermosensitive mutant , 1991, Journal of Hepatology.
[40] M. Perricaudet,et al. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level. , 1991, Biochemical and biophysical research communications.
[41] A. Siddiqui,et al. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions , 1991, Science.
[42] M. Höhne,et al. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. , 1990, The EMBO journal.
[43] P. Hofschneider,et al. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator , 1990, Nature.
[44] M. Perricaudet,et al. Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen. , 1989, Virology.
[45] D. Shalloway,et al. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF , 1987, Nature.
[46] J. Yates,et al. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus , 1985, Molecular and cellular biology.
[47] T. Yen. Hepadnaviral X Protein:Review of Recent Progress. , 1996, Journal of biomedical science.
[48] M. Lai,et al. Activation of protooncogene c-jun by the X protein of hepatitis B virus. , 1993, Virology.